Mitsubishi Chemical : Announcement of launch of SGLT2 inhibitor "CANAGLU OD Tablets" ～Adoption of Environmentally Friendly Biomass-plastic PTP Sheets～NEW marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Mitsubishi Tanabe Pharma Corporation , a member of the Mitsubishi Chemical Group, announced today, that Health Canada has approved RADICAVA® Oral Suspension for the treatment of patients. | November 9, 2022